FDA Approves Zilbrysq for Generalized Myasthenia Gravis

TUESDAY, Oct. 24, 2023 (HealthDay News) -- The U.S. Food and Drug Administration has approved Zilbrysq (zilucoplan) for the treatment of adults with generalized myasthenia gravis.Zilbrysq is a targeted...